Publications by authors named "Sharon Murray"

Claim this Profile
O
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
Bruce Zuraw, William R Lumry, Douglas T Johnston, Emel Aygören-Pürsün, Aleena Banerji, Sharon C Murray

J Allergy Clin Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial.
Isao Ohsawa, Daisuke Honda, Yusuke Suzuki, Tomoo Fukuda, Keisuke Kohga, Sharon C Murray

Allergy· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2).
H James Wedner, Emel Aygören-Pürsün, Jonathan Bernstein, Timothy Craig, Richard Gower, Sharon C Murray

J Allergy Clin Immunol Pract· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of berotralstat for hereditary angioedema: The open-label APeX-S study.
Henriette Farkas, Marcin Stobiecki, Jonny Peter, Tamar Kinaciyan, Marcus Maurer, Sharon C Murray

Clin Transl Allergy· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Tactics to Strategy: Creating and Sustaining Social Conditions That Demand and Deliver Effective School Health Programs.
Michael J Mann, Alfgeir L Kristjansson, Megan L Smith, Shay M Daily, Sabena Thomas, Sharon Murray

J Sch Health· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting the whole child through coordinated policies, processes, and practices.
Sharon D Murray, James Hurley, Shannon R Ahmed

J Sch Health· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacokinetic, pharmacodynamic, and safety study of intravenous cyclophosphamide with an oral casopitant antiemetic regimen in cancer patients.
Laurel M Adams, Brendan Johnson, Sharon Murray

Clin Pharmacol Drug Dev· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-Hodgkin lymphoma.
Michael J Robertson, Justin Kline, Herbert Struemper, Kevin M Koch, John W Bauman, Sharon C Murray

J Immunother· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoimmunotherapy using pegylated liposomal Doxorubicin and interleukin-18 in recurrent ovarian cancer: a phase I dose-escalation study.
Fiona Simpkins, Aurea Flores, Christina Chu, Jonathan S Berek, Joseph Lucci, Sharon Murray

Cancer Immunol Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist.
John W Bauman, Joyce M Antal, Laurel M Adams, Brendan M Johnson, Sharon C Murray

Invest New Drugs· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies.
David Olmos, Douglas Barker, Rohini Sharma, Andre T Brunetto, Timothy A Yap, Sharon C Murray

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer.
Uday B Dandamudi, Laurel M Adams, Brendan Johnson, John Bauman, Shannon Morris, Sharon Murray

Cancer Chemother Pharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caesarean section and macrosomia increase transient tachypnoea of the newborn in type 1 diabetes pregnancies.
Rany Al-Agha, Brendan T Kinsley, Francis M Finucane, Sharon Murray, Sean Daly

Diabetes Res Clin Pract· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy volunteers and patients with type 2 diabetes mellitus.
Elizabeth K Hussey, Richard V Clark, Dipti M Amin, Mark S Kipnes, Robin L O'Connor-Semmes, Sharon C Murray

J Clin Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study.
Elizabeth K Hussey, Robert L Dobbins, Randall R Stoltz, Nancy L Stockman, Robin L O'Connor-Semmes, Sharon C Murray

J Clin Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of casopitant, a novel NK-1 receptor antagonist, on the pharmacokinetics and pharmacodynamics of steady-state warfarin.
Lyndon C Kirby, Brendan M Johnson, Laurel M Adams, Derek J Eberwein, Ke Zhang, Sharon C Murray

J Clin Pharmacol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample size calculations for crossover thorough QT studies: satisfaction of regulatory threshold and assay sensitivity.
Suraj P Anand, Sharon C Murray, Gary G Koch

J Biopharm Stat· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus type 1 protease inhibitor, following repeat administration with and without ritonavir in healthy adult subjects.
Y Sunila Reddy, Susan L Ford, Maggie T Anderson, Sharon C Murray, Judith Ng-Cashin

Antimicrob Agents Chemother· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful strategies and lessons learned from development of large-scale partnerships of national non-governmental organisations.
William Potts-Datema, Becky J Smith, Howard Taras, Theresa C Lewallen, James F Bogden, Sharon Murray

Promot Educ· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus protease inhibitor.
Susan L Ford, Y Sunila Reddy, Maggie T Anderson, Sharon C Murray, Pedro Fernandez

Antimicrob Agents Chemother· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study.
Peadar N Kirke, James L Mills, Anne M Molloy, Lawrence C Brody, Valerie B O'Leary, Sharon Murray

BMJ· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration.
Virgil A Marple, Bernard A Olson, Kumaragovindham Santhanakrishnan, Jolyon P Mitchell, Sharon C Murray

J Aerosol Med· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis